Affinity Asset Advisors’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66M Hold
250,000
0.14% 89
2025
Q4
$2.65M Hold
250,000
0.15% 76
2025
Q3
$2.66M Hold
250,000
0.23% 68
2025
Q2
$2.65M Hold
250,000
0.36% 50
2025
Q1
$2.6M Hold
250,000
0.25% 60
2024
Q4
$2.54M Buy
+250,000
New +$2.52M 0.34% 55

Other funds holding OACCU

Affinity Asset Advisors's OACCU Position: Q1 2026 in Review

Affinity Asset Advisors held its Oaktree Acquisition Corp III Life Sciences Unit (OACCU) position steady in Q1 2026 at 250,000 shares worth $2.66M. The position accounts for 0.14% of the portfolio, ranked #89.

Affinity Asset Advisors first reported a position in OACCU in Q4 2024 and has held it in 6 quarters since. 6 funds tracked by Wall St. Rank hold OACCU as of Q1 2026.

  • Affinity Asset Advisors held 250,000 shares of Oaktree Acquisition Corp III Life Sciences Unit worth $2.66M as of Q1 2026.
  • Affinity Asset Advisors left its Oaktree Acquisition Corp III Life Sciences Unit share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Unit made up 0.14% of Affinity Asset Advisors's portfolio in Q1 2026, its #89 holding.
  • Affinity Asset Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and has held it in 6 quarters since.
  • 6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.